Pharmacological blockage of the AHR-CYP1A1 axis: a call for in vivo evidence

The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that can be activated by structurally diverse compounds arising from the environment and the microbiota and host metabolism. Expanding evidence has been shown that the modulation of the canonical pathway of AHR occurs dur...

Descripción completa

Detalles Bibliográficos
Autores principales: Coelho, N. R., Pimpão, A. B., Correia, M. J., Rodrigues, T. C., Monteiro, E. C., Morello, J., Pereira, S. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605459/
https://www.ncbi.nlm.nih.gov/pubmed/34800164
http://dx.doi.org/10.1007/s00109-021-02163-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605459/
https://www.ncbi.nlm.nih.gov/pubmed/34800164
http://dx.doi.org/10.1007/s00109-021-02163-2

Ejemplares similares